Roth Capital


Roth Capital Reiterates Buy Rating, $90 PT On Power Solutions

In a research report released this morning, Roth Capital analyst Philip Shen reiterated coverage with a “Buy” rating on Power Solutions International, Inc. (PSIX), and a price …

Roth Capital Maintains Buy On China Cord Blood Corporation, Increases PT To $6

In a research note issued this morning, Roth Capital analyst Scott Henry maintained a Buy rating on China Cord Blood Corporation (CO) and raised his price target to $6.00 (from $5.

Roth Capital Maintains Buy On Golden Minerals, Increases Price Target To $1.20

In a research note issued today, Roth Capital analyst Joseph Reagor maintained a Buy rating on Golden Minerals Company (AUMN) and raised his price target to …

Roth Capital Reiterates Buy On Summer Infant, Boosts Price Target To $3.50

Roth Capital recently hosted investor meetings with Summer Infant’s (SUMR) management and came away highly impressed by new CEO Carol Bramson’s strategic vision …

Roth Capital Reiterates Buy On Crown Crafts Following 4QFY14 Earnings

In a research note released this morning, Roth Capital analyst Dave King reiterated coverage with a “Buy” rating on Crown Crafts, Inc. (CRWS), and a price target of $9.

Roth Capital Reiterates Buy On Derma Sciences Following Analyst Day;Revising Estimates

In a research note released this morning, Roth Capital analyst Scott Henry reiterated coverage with a “Buy” rating on Derma Sciences Inc. (DSCI) and …

Roth Capital Maintains Buy Rating On Tonix Following A Physician Conference Call

In a research note issued today, Roth Capital analyst Scott Henry maintained coverage with a “Buy” rating on Tonix Pharmaceuticals Holding Corp (TNXP) and a …

Roth Capital Raises Price Target On EnteroMedics Following FDA Panel Recommendation

In a research note issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating and boosted his price target on EnteroMedics Inc. (ETRM) to $5.

Roth Capital Reiterates Buy Rating On SolarCity;Raises Price Target to $80

Following SolarCity Corporation (SCTY) announcement that it plans to acquire high-efficiency module manufacturer Silevo for $200mn in a stock-based transaction, Roth Capital analyst Philip Shen …

Roth Capital Initiates Coverage On Prosensa At Neutral; Sets $12 Price Target

In a research note released this morning, Roth Capital analyst Debjit Chattopadhyay initiated coverage with a “Neutral” rating on Prosensa Holding N.V.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts